LitAlert ~~ GeneLit.com

    • Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry.
    • Choudhury PP, Brook MN, Hurson AN, Lee A, Mulder CV, Coulson P, Schoemaker MJ, Jones ME, Swerdlow AJ, Chatterjee N, Antoniou AC, Garcia-Closas M.
    • Breast Cancer Res. 2021 Feb 15;23(1):22. doi: 10.1186/s13058-021-01399-7.
    • When in the Treatment Continuum to Use PARP Inhibition in Ovarian Cancer.
    • Mirza MR.
    • Clin Adv Hematol Oncol. 2021 Feb;19(2).
    • A Review of Cancer Genetics and Genomics Studies in Africa.
    • Rotimi SO, Rotimi OA, Salhia B.
    • Front Oncol. 2021 Feb 15;10:606400. doi: 10.3389/fonc.2020.606400.
    • Implications of Multigene Panel Testing on Psychosocial Outcomes: A Comparison of Patients With Pancreatic and Breast or Ovarian Cancer.
    • Koptiuch C, Espinel WF, Kohlmann WK, Zhao J, Kaphingst KA.
    • JCO Precis Oncol. 2020;5:235-244. doi: 10.1200/PO.20.00199. Epub 2021 Jan 19.